Identification of a Novel Mutation in the COL2A1 Gene in a Chinese Family with Spondyloepiphyseal Dysplasia Congenita

PLoS One. 2015 Jun 1;10(6):e0127529. doi: 10.1371/journal.pone.0127529. eCollection 2015.

Abstract

Spondyloepiphyseal dysplasia congenita (SEDC) is an autosomal dominant chondrodysplasia characterized by disproportionate short-trunk dwarfism, skeletal and vertebral deformities. Exome sequencing and Sanger sequencing were performed in a Chinese Han family with typical SEDC, and a novel mutation, c.620G>A (p.Gly207Glu), in the collagen type II alpha-1 gene (COL2A1) was identified. The mutation may impair protein stability, and lead to dysfunction of type II collagen. Family-based study suggested that the mutation is a de novo mutation. Our study extends the mutation spectrum of SEDC and confirms genotype-phenotype relationship between mutations at glycine in the triple helix of the alpha-1(II) chains of the COL2A1 and clinical findings of SEDC, which may be helpful in the genetic counseling of patients with SEDC.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Asian People
  • Collagen Type II / deficiency*
  • Collagen Type II / genetics
  • Exome / genetics
  • Female
  • Genetic Association Studies
  • Humans
  • Male
  • Mutation / genetics
  • Osteochondrodysplasias / congenital*
  • Osteochondrodysplasias / genetics
  • Pedigree
  • Young Adult

Substances

  • COL2A1 protein, human
  • Collagen Type II

Supplementary concepts

  • Spondyloepiphyseal dysplasia, congenita

Grants and funding

This work was supported by National Natural Science Foundation of China (81101339, 81001476, 81441033); Natural Science Foundation of Hunan Province, China (10JJ4020, 10JJ5029); Postgraduates Innovative Pilot Scheme of Hunan Province (7138000008), China; Fundamental Research Funds for the Central Universities of Central South University (2014zzts368); and the Construction Fund for Key Subjects of the Third Xiangya Hospital, Central South University, China.